Antiherpethetical medication :: Consumers survey results of for 3 quarter of 2024

Consumers survey results of for 3 quarter of 2024 in category

Antiviral medications / Antiherpethetical medication

The annual ratings by results of Consumers survey calculated as average arithmetic mean rank, obtained in each of 4 quarters of year.

	I quarter (january—march)
	II quarter (april—june)
	III quarter (july—september)
	IV quarter (october—december)

1.	Аміксин IC (InterChem)	100.00%	5

1.	Ацикловір (Nizhpharm)	100.00%	5

3.	Анаферон (Materia Medica – Ukraine)	50.00%	2.50

3.	Ацик (Sandoz)	50.00%	2.50

–.	Lipster (Farmak)	0.00%	0

–.	Viferon (Feron)	0.00%	0

–.	Zovirax (GlaxoSmithKline)	0.00%	0

–.	Іммустат (Darnitsa)	0.00%	0

–.	Алломедин (Nizhpharm)	0.00%	0

–.	Валавір (Farmak)	0.00%	0

–.	Герпевір (Arterium Corporation)	0.00%	0

–.	Гропринозин (Gedeon Richter)	0.00%	0

–.	Доктор БіоконThe products of TM “Доктор Біокон” is not a medications. This is a dietary supplement, a cosmetic, or other kind of non-pharmaceutical products.');return false;">	0.00%	0

–.	Ергоферон (Materia Medica – Ukraine)	0.00%	0

–.	Кагоцел (Ніармедик Плюс)	0.00%	0

–.	Лавомакс (Nizhpharm)	0.00%	0

–.	Оксолін-Дарница (Darnitsa)	0.00%	0

–.	Фенистил Пенцивир (Novartis OTC)	0.00%	0

This rating reflects the current interim results of the study of public opinion as on 11/03/2024 13:36:07 and it’s not yet final.

Strictly prohibited any use and reproduction of unfinished voting results without link to the source, without clear explanation of the methodology of the “Favorites of Success” Contest and without mandatory notes that poll is still continues and this result is not yet final.